ISB News

Event: Cancer Think Tank

Cure First is hosting the forum “Cancer Think Tank.” Speakers include ISB’s Dr. Ilya Shmulevich and Dr. Brady Bernard.

Date: January 21, 2016
Time: 1-5:30 p.m. MED talks, breakout sessions, and panel discussion; 6-8 p.m. networking with wine and dinner
Why: To jump start innovative collaborations in cancer research with the goal to submit proposals for funding to accelerate the discovery of new, less toxic and targeted therapies.
Who: This event is for you if you are a practicing specialist and interested in any of the following specialties: clinical oncology, computational sciences, patient advocacy, pharmaceutical R&D, cancer research, and genetics.
Where: Kakao, 415 Westlake Ave N, Seattle, WA 98109
Speakers: list

Cure First is bringing together from a variety of disciplines including research, clinical, computational science, pharmaceutical science, healthcare investment, to share their work and vision about the realities of what precision medicine can bring to cancer patients. With new high throughput screening (HTS) capabilities, we can now test hundreds of genes and target those that are cancer specific for more effective, less toxic therapies. Cancer Think Tank will provide a forum for experts to consider these and other approaches to identify new possibilities and further our understanding of how to kill cancer.

Agenda: New ideas and insights into potentially disruptive science and technology will b e shared through MED Talk presentations. In small working groups, facilitators will ask for ideas and examples of what can be done to develop new approaches for treating cancer. Research themes will surface from group interactions and be shared with the larger group for further investigation. From this exchange of ideas, topics for grants will be identified and sent out after the event to Cancer Think Tank participants for review. The afternoon will close with social networking, dinner and drinks.

Results: Funding for specific initiatives emerging from the conference will be pursued in the months following. Participants interested in working with other specialists will be invited to write segments of grant applications using a structured approach for faster development and strategic submission to funding institutions such as the NIH and NCI.

REGISTER

 

Recent Articles

  • Understanding, Preventing and Treating Long-Term Effects of COVID: RECOVER Study Enrolling Patients from Pacific Northwest

    As part of a massive nationwide effort, ISB is leading a multi-site consortium for the NIH RECOVER (Researching COVID to Enhance Recovery) Initiative. The Pacific Northwest consortium is made up of ISB, Providence, Swedish, and University of Washington School of Medicine.

  • Spotlight on ISB Education graphic

    2021-22 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2021-2022 academic year, we will highlight some of the top projects the team is working on.

  • Jim Heath AACR Academy Fellow

    Dr. Jim Heath Named Fellow of AACR Academy Class of 2022

    Dr. Jim Heath was announced as a newly elected Fellow of the American Academy for Cancer Research (AACR) Academy Class of 2022. “I am honored and humbled to be recognized as part of this renowned group of researchers who have done so much to move our understanding of cancer forward,” Heath said.